Tag Archives: Alex Lash

Acer Therapeutics Announces Reverse Merger With Houston’s Opexa

[Updated 6/6/17, 8:04 am] Houston—Opexa Therapeutics is the target of a reverse merger with Acer Therapeutics, a privately held pharmaceutical company based in the Boston area. In a filing with the US Securities and Exchange Commission Monday, the companies announced the arrangement and also said that Cambridge, MA-based Acer would receive $15.7 million in a financing […]

Same Twist, New Funding: Gene Synthesizer Raises $61M Series D

Twist Bioscience is reeling in millions more in funding as the company, which has developed a process of manufacturing synthetic DNA, plans to expand in the U.S. and internationally. Based in San Francisco, Twist announced a $61 million Series D round of funding alongside a piece of debt financing for as much as $20 million. […]

Posted in Boston blog main, National blog main, San Francisco, San Francisco blog main, San Francisco top stories | Tagged Alex Lash, ARCH Overage Fund, ARCH Venture Partners, bank financing, Boris Nikolic, Cormorant Asset Management LLC, Debt Financing, designing organisms, DNA, Emily LeProust, Fidelity Management and Research Company, Foresite Capital Management, gene sequence, gene sequencing, Ginkgo BioWorks, Illumina, investing, Life Sciences, loan, manufacturing DNA, Merieux Developpement, Nick and Joby Pritzker, organism design, organisms, Paladin Capital Group, revolving credit line, Silicon Valley Bank, synthesize genes, synthesizing genes, Synthetic DNA, Tao Invest, term loan, Twist, TWist Bioscience, Twist DNA, Venture Capital, Venture Funding, WuXi Healthcare Ventures, Yuri Milner | Comments Off

Data Gatherer Turned Drug Developer 23andMe Raises $79.1M, Wants More

23andMe, the data gatherer turned drug developer, appears to be raising $150 million of new funding, according to a document filed July 2 with the Securities and Exchange Commission. The company has sold $79.1 million in the offering so far, according to the document, which shows at least part of the funding was for Series […]

Posted in National blog main, San Francisco, San Francisco blog main, San Francisco top stories | Tagged 23andMe, Alex Lash, Andrew Page, andy page, Biotech, chromosome, data gatherer, data-gathering, drug developer, Drug Development, exome, Finance, Financing, funding, fundraise, gene, Genentech, genes, Genome, Life Science, Life Sciences, Richard Scheller, SEC, Securities and Exchange Commission, Series E, spokesman, Xconomy | Comments Off

GE Backs Evidation Health to Tackle Digital Health

[Updated 3/5/14 5:17 pm. See below.] Digital health is an amorphous category that can encompass everything from electronic health records to fitness apps. It’s been hard to grasp the real value of some of these technologies, as Xconomy’s Alex Lash examined in detail in October. GE Ventures is trying to address that problem. The firm […]

Posted in National blog main, National top stories, San Francisco, San Francisco blog main, San Francisco top stories | Tagged acquisitions, Alex Lash, Analytics, Asset Management Ventures, Biogen Idec, CardioDx, Christine Lemke, deals, Deborah Kilpatrick, Digital Health, Electronic Health Records, Evidation Health, Financing, Fitness Apps, funding, GE Ventures, harvard business school, Healthtech, Humana, innovation, Internet, IT, Life Sciences, Mohr Davidow, Predictive Analytics, Rock Health, Rowan Chapman, SanFranciscoVC, Sanofi, Series A, Software, Stanford Health Care, startups, The Activity Exchange, VC, Venture Capital, Web, Xconomy | Comments Off

A Big Day for Xconomy: Introducing Elise Craig and Alex Lash

At a growing media startup like Xconomy, there’s no task more thrilling than welcoming new editors and writers on board. Today is especially exciting, because I’ve got not one but two additions to tell you about. First, I’m extremely pleased to announce that Elise Craig has joined us as the new Editor of Xconomy San […]

Posted in Boston blog main, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, National blog main, National top stories, New York blog main, New York top stories, San Diego blog main, San Diego top stories, San Francisco, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Wisconsin blog main, Wisconsin top stories | Tagged Alex Lash, Elise Craig, IT, Life Sciences, San Francisco, startups, Xconomy | 3 Comments